Medicare Enrolled
Dr. Farah Dawood-Farah, MD
Endocrinology · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dawood-Farah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dawood-Farah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dawood-Farah
Dr. Farah Dawood-Farah is an endocrinology specialist in Rochester Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dawood-Farah performed 8,699 Medicare services across 3,291 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dawood-Farah received a total of $13,417 from 66 pharmaceutical and/or device companies across 720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dawood-Farah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in MI
$13,417 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,699
Medicare services
Top 1% in MI for endocrinology
3,291
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~435 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
4,364 | $64 | $155 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,235 | $92 | $200 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
693 | $9 | $35 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
623 | $3 | $10 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
561 | $104 | $290 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
320 | $8 | $10 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
310 | $26 | $115 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
266 | $138 | $425 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
106 | $121 | $310 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
98 | $96 | $220 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
57 | $16 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $67 | $140 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
21 | $73 | $115 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
12 | $49 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,417
Total received (2018-2024)
Avg $1,917/year across 7 years
Top 20% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
66
Companies
720
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,417 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,533
2023
$2,412
2022
$2,135
2021
$1,690
2020
$1,261
2019
$1,452
2018
$1,934
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$472
SANOFI-AVENTIS U.S. LLC
$306
Novo Nordisk Inc
$256
Amgen Inc.
$180
Abbott Laboratories
$167
MIMEDX Group, Inc.
$131
Amneal Pharmaceuticals LLC
$117
Xeris Pharmaceuticals, Inc.
$117
ABBVIE INC.
$112
CARDIVA MEDICAL, INC.
$87
Tolmar, Inc.
$85
Corcept Therapeutics
$79
Ascensia Diabetes Care Us Inc.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
CeQur Corporation
$42
BETA BIONICS, INC.
$42
Amphastar Pharmaceuticals, Inc.
$39
Alexion Pharmaceuticals, Inc.
$28
RECORDATI_RARE_DISEASES_INC.
$25
Neurocrine Biosciences, Inc.
$22
Insulet Corporation
$20
Chiesi USA, Inc.
$20
Alvogen Inc
$19
Radius Health, Inc.
$18
AIMMUNE THERAPEUTICS, INC.
$18
Mannkind Corporation
$13
TheracosBio, LLC
$11
Top 3 companies account for 40.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$1,562
Novo Nordisk Inc
$1,481
SANOFI-AVENTIS U.S. LLC
$1,453
AstraZeneca Pharmaceuticals LP
$930
Amgen Inc.
$800
Abbott Laboratories
$729
Amneal Pharmaceuticals LLC
$561
Dexcom, Inc.
$498
Medtronic MiniMed, Inc.
$368
Boehringer Ingelheim Pharmaceuticals, Inc.
$335
Xeris Pharmaceuticals, Inc.
$312
Corcept Therapeutics
$302
BIOTRONIK INC.
$281
AbbVie Inc.
$223
Janssen Pharmaceuticals, Inc
$212
Medtronic, Inc.
$212
Shire North American Group Inc
$196
Horizon Therapeutics plc
$164
Becton, Dickinson and Company
$157
ABBVIE INC.
$151
CeQur Corporation
$150
Merck Sharp & Dohme Corporation
$146
MIMEDX Group, Inc.
$131
RECORDATI_RARE_DISEASES_INC.
$126
Insulet Corporation
$116
Bayer HealthCare Pharmaceuticals Inc.
$111
Medtronic Vascular, Inc.
$109
Antares Pharma, Inc.
$106
AbbVie, Inc.
$100
CARDIVA MEDICAL, INC.
$87
Tolmar, Inc.
$85
Mannkind Corporation
$84
Allergan Inc.
$77
Tandem Diabetes Care, Inc.
$69
Ascensia Diabetes Care Us Inc.
$64
EUSA Pharma (US) LLC
$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$61
Embecta Corp.
$57
Amryt Pharma Holdings Ltd
$53
Radius Health, Inc.
$47
Alexion Pharmaceuticals, Inc.
$47
Supernus Pharmaceuticals, Inc.
$44
Acerus Pharmaceuticals Corporation
$42
BETA BIONICS, INC.
$42
Amphastar Pharmaceuticals, Inc.
$39
Melinta Therapeutics, Inc.
$39
Zealand Pharma US, Inc.
$38
Nevro Corp.
$31
MannKind Corporation
$29
Amarin Pharma Inc.
$27
Clarus Therapeutics Inc.
$23
Neurocrine Biosciences, Inc.
$22
Chiesi USA, Inc.
$20
Mylan Institutional Inc.
$19
Alvogen Inc
$19
Merck Sharp & Dohme LLC
$18
AIMMUNE THERAPEUTICS, INC.
$18
Gilead Sciences, Inc.
$18
IBSA Pharma Inc.
$17
Ultragenyx Pharmaceutical Inc.
$16
Valeritas, Inc.
$16
Ipsen Biopharmaceuticals, Inc
$14
Nestle HealthCare Nutrition Inc.
$14
PFIZER INC.
$14
Cardiovascular Systems Inc.
$11
TheracosBio, LLC
$11
Top 3 companies account for 33.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · Brenzavvy · CARDIVA VASCADE MVP VVCS 6-12F · CYCLOSET · CeQur Simplicity · Cimduo · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dexcom CGM · Dexcom G6 Transmitter · ENSOETM · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN U · IN.PACT Admiral · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · Macrilen · Micra · Minimed 670G System · Minimed 770G System · NATPARA · NOCDURNA · Natesto · Omnipod · Orbactiv · Ozempic · Peripheral Orbital Atherectomy System · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SAVVYWIRE · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Senza · Strensiq · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vabomere · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZENPEP · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
75
Per 100K population
5.9
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dawood-Farah is a clinical cardiology specialist, with above-average Medicare volume (top 1% in MI), with low-engagement industry engagement in the top 20% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dawood-Farah experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Dawood-Farah performed 4,364 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dawood-Farah receive payments from pharmaceutical companies?
Yes. Dr. Dawood-Farah received a total of $13,417 from 66 companies across 720 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dawood-Farah's costs compare to other endocrinologists in Rochester Hills?
Dr. Dawood-Farah's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dawood-Farah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Rochester Hills
Browse endocrinologists in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology